InnovAge Holding Corp
NASDAQ:INNV

Watchlist Manager
InnovAge Holding Corp Logo
InnovAge Holding Corp
NASDAQ:INNV
Watchlist
Price: 5.3 USD -3.28%
Market Cap: 719.1m USD
Section:
 

Relative Value

The Relative Value of one INNV stock under the Base Case scenario is 7.53 USD. Compared to the current market price of 5.3 USD, InnovAge Holding Corp is Undervalued by 30%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

INNV Relative Value
Base Case
7.53 USD
Undervaluation 30%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.8
P/S
P/S
Price to Sales
0.8
vs History
69
vs Industry
77
Median 3Y
0.9
Median 5Y
1
Industry
2.4
Forward
0.8
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
19
Median 3Y
-23
Median 5Y
-21.6
Industry
22.9
Forward
23.1
More Details
16.3
P/OCF
P/OCF
Price to OCF
16.3
vs History
47
vs Industry
2
Median 3Y
13.8
Median 5Y
15.9
Industry
14.7
More Details
32.4
P/FCFE
P/FCFE
Price to FCFE
32.4
vs History
11
vs Industry
16
Median 3Y
-14.3
Median 5Y
-15
Industry
21.4
More Details
2.9
P/B
P/B
Price to Book Value
2.9
vs History
30
vs Industry
47
Median 3Y
2.8
Median 5Y
2.6
Industry
2.3
More Details
0.8
EV/S
EV/S
Enterprise Value to Sales
0.8
vs History
63
vs Industry
79
Median 3Y
0.9
Median 5Y
0.9
Industry
2.6
Forward
0.7
More Details
3.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.9
vs History
60
vs Industry
60
Median 3Y
5.4
Median 5Y
4.7
Industry
5.3
More Details
41.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
41.2
vs History
30
vs Industry
1
Median 3Y
-25.9
Median 5Y
15.8
Industry
12.3
Forward
10.7
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
32
Median 3Y
-21.5
Median 5Y
-20.2
Industry
17.2
Forward
22.7
More Details
15.2
EV/OCF
EV/OCF
Enterprise Value to OCF
15.2
vs History
41
vs Industry
3
Median 3Y
12.1
Median 5Y
14.9
Industry
15
More Details
18.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
18.6
vs History
15
vs Industry
23
Median 3Y
-17.1
Median 5Y
-32.1
Industry
19
More Details
1.9
EV/IC
EV/IC
Enterprise Value to IC
1.9
vs History
47
vs Industry
56
Median 3Y
1.9
Median 5Y
1.9
Industry
1.9
More Details

Multiples Across Competitors

INNV Competitors Multiples
InnovAge Holding Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
InnovAge Holding Corp
NASDAQ:INNV
719.1m USD 0.8 -41.4 41.2 -235.3
US
CVS Health Corp
NYSE:CVS
101.5B USD 0.3 215.9 14.1 14.1
US
Cigna Corp
NYSE:CI
73.4B USD 0.3 11.9 7.7 9.8
US
Cigna Group
XMUN:CGN
63.8B EUR 0.3 12.1 7.8 9.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
28.5B EUR 1.3 24.9 10.8 16.4
DE
Fresenius Medical Care AG
XMUN:FME
23.4B EUR 1.2 31.8 10.3 21.9
US
Laboratory Corporation of America Holdings
NYSE:LH
20.9B USD 1.5 24.4 13.4 18.7
US
Quest Diagnostics Inc
NYSE:DGX
19.5B USD 1.8 20.1 11.2 15.2
US
Guardant Health Inc
NASDAQ:GH
13.9B USD 14.7 -33.3 -36.6 -33.2
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.8B EUR 0.6 15.9 6.4 13.7
US
DaVita Inc
NYSE:DVA
7.9B USD 0.6 10.1 6.6 8.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
InnovAge Holding Corp
NASDAQ:INNV
Average EV/EBIT: 14.3
Negative Multiple: -235.3 		N/A N/A
US
CVS Health Corp
NYSE:CVS
14.1
19%
0.7
US
Cigna Corp
NYSE:CI
9.8
5%
2
US
C
Cigna Group
XMUN:CGN
9.9
5%
2
DE
Fresenius SE & Co KGaA
XETRA:FRE
16.4
20%
0.8
DE
Fresenius Medical Care AG
XMUN:FME
21.9
25%
0.9
US
Laboratory Corporation of America Holdings
NYSE:LH
18.7
27%
0.7
US
Quest Diagnostics Inc
NYSE:DGX
15.2
11%
1.4
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -33.2 N/A N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13.7
25%
0.5
US
DaVita Inc
NYSE:DVA
8.9
4%
2.2

See Also

Summary
INNV intrinsic value, competitors valuation, and company profile.
DCF Valuation
INNV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
INNV stock valuation using valuation multiples.
Wall Street Estimates
INNV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
INNV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 309,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.